Inhibiting PI-3-K for glioma therapy

Cell Cycle

Volumn 8, Issue 3, 2009, Pages 335-

  Powis, Garth ^a   Ihle, Nathan T ^a   Yung, W K Alfred ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 (4 HYDROXYPHENYL) 4 MORPHOLINOPYRIDO[3',2':4,5]FURO[3,2 D]PYRIMIDINE; 2 MORPHOLINO 8 PHENYLCHROMONE; CARMUSTINE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PI 387; PROTEIN KINASE B; TEMOZOLOMIDE; UNCLASSIFIED DRUG; VINCRISTINE;

CANCER CHEMOTHERAPY; CELL KILLING; CELL PROLIFERATION; CELL SURVIVAL; CYTOSTASIS; DRUG POTENTIATION; ENZYME INHIBITION; GENE MUTATION; GLIOBLASTOMA; GLIOMA; HUMAN; NONHUMAN; SHORT SURVEY;

EID: 59449106614     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.8.3.7884     Document Type: Short Survey

References (5)

1. Hartmann C, et al. Acta Neuropathol 2005; 109:639-42.
2. Guillard S, et al. Cell Cycle 2009; 8: In this issue.
3. Wipf P, et al. Org Biomol Chem 2004; 2:1911-20.
4. Fan QW, et al. Cell Cycle 2006; 5:2301-5
5. Webster KA. Antioxid Redox Signal 2007; 9:1303-7.